Abstract:Background and objective: The updated World Health Organization (WHO) air quality guideline recommends an annual mean concentration of fine particulate matter (PM2.5) not exceeding 5 or 15 μg/m3 in the short-term (24 h) for no more than 3-4 days annually. However, more than 90% of the global population is currently exposed to daily concentrations surpassing these limits, especially during extreme weather conditions and due to transboundary dust transport influenced by climate change. Herein, the effect of respirable <PM2.5 inorganic silica particle exposures on epithelial barrier integrity was simultaneously evaluated within the biomimetic microfluidic platform-based airway epithelial barrier (AEB)-on-a-chip and human bronchoscopic ex vivo airway tissue models, comparatively. Methods: Silica particles at an average size of 1 μm, referred to as <PM2.5, dose-dependently tested by MTT and LDH analyses. The elicited dose of 800 μg/mL was applied to human airway epithelial cells (Calu-3) seeded to the membrane at air-liquid interface in the AEB-on-a-chip platform, which is operated under static and dynamic conditions and to ex vivo human bronchoscopy bronchial tissue slices for 72 h. For both models, healthy and exposed groups were comparatively investigated. Computational fluid dynamics simulations were performed to assess shear stress profiles under different flow conditions. Qualitative and quantitative analyses were carried out to evaluate the resilience of the epithelial barrier via cell survivability, morphology, barrier integrity, permeability, and inflammation. Results: In the AEB-on-a-chip platform, short-term exposure to 800 μg/mL PM2.5 disrupted AEB integrity via increasing barrier permeability, decreasing cell adhesion-barrier markers such as ZO-1, Vinculin, ACE2, and CD31, impaired cell viability and increased the expression levels of proinflammatory markers; IFNs, IL-6, IL-1s, TNF-α, CD68, CD80, and Inos, mostly under dynamic conditions. Besides, decreased tissue viability, impaired tissue integrity via decreasing of Vinculin, ACE2, β-catenin, and E-cadherin, and also proinflammatory response with elevated CD68, IL-1α, IL-6, IFN-Ɣ, Inos, and CD80 markers, were observed after PM2.5 exposure in ex vivo tissue. Conclusion: The duration and concentration of PM2.5 that can be exposed during extreme weather conditions and natural events aligns with our exposure model (0-800 μg/mL 72 h). At this level of exposure, the resilience of the epithelial barrier is demonstrated by both AEB-on-a-chip platform emulating dynamic forces in the body and ex vivo bronchial biopsy slices. Lung-on-a-chip models will serve as reliable exposure models in this context.

Development of alveolar-capillary-exchange (ACE) chip and its application for assessment of PM2.5-induced toxicity

Assessment of Air Pollutant PM2.5 Pulmonary Exposure Using a 3D Lung-on-Chip Model

Ambient fine particulate matter induce toxicity in lung epithelial-endothelial co-culture models

Co-culture of Human Alveolar Epithelial (A549) and Macrophage (THP-1) Cells to Study the Potential Toxicity of Ambient PM2.5: a Comparison of Growth under ALI and Submerged Conditions

Evaluation of Pm2.5 Influence on Human Lung Cancer Cells Using a Microfluidic Platform

Analysis of the Response to Cigarette Smoke Exposure in Cell Coculture and Monoculture Based on Bionic-Lung Microfluidic Chips

Advances of microfluidic lung chips for assessing atmospheric pollutants exposure

Assessing the Adverse Impacts of PM2.5 on Olfactory System Using an Air-liquid Interface Culture Model of Primary Olfactory Epithelial Cells

Evaluation of cigarette smoke-induced oxidative stress and inflammation in BEAS-2B cells based on a lung microfluidic chip

Cytotoxicity Analysis of Biomass Combustion Particles in Human Pulmonary Alveolar Epithelial Cells on an Air–liquid Interface/dynamic Culture Platform

Cytotoxicity Analysis of Ambient Fine Particle in BEAS-2B Cells on an Air-Liquid Interface (ALI) Microfluidics System.

Comprehensive analysis of resilience of human airway epithelial barrier against short-term PM2.5 inorganic dust exposure using in vitro microfluidic chip and ex vivo human airway models

A Microfluidic Lung-on-a-chip Based on Biomimetic Hydrogel Membrane

Investigation of Environmental Pollutant-Induced Lung Inflammation and Injury in a 3D Coculture-Based Microfluidic Pulmonary Alveolus System

A New Immortalized Human Alveolar Epithelial Cell Model to Study Lung Injury and Toxicity on a Breathing Lung-On-Chip System

In vitro assessment of ferroptosis of cells exposed to cigarette smoke aerosol using a self-designed on-chip evaluation system based on gas-liquid dual-dimensional exposure

The effect of PM2.5 exposure on lung inflammation and mitochondrial dysfunction using a macrophage-alveolar organoid co-culture system

An Air-Liquid Interface Organ-Level Lung Microfluidics Platform for Analysis on Molecular Mechanisms of Cytotoxicity Induced by Cancer-Causing Fine Particles.

In Vitro Toxicity Assessment of Atmospheric Particulate Matter on Human Lung and Hepatic Cells with Agar Membrane-Based Sampling and Exposure Strategy

Combining a Lung Microfluidic Chip Exposure Model with Transcriptomic Analysis to Evaluate the Inflammation in BEAS-2B Cells Exposed to Cigarette Smoke

Comparative study of the effects of PM1-induced oxidative stress on autophagy and surfactant protein B and C expressions in lung alveolar type II epithelial MLE-12 cells